PRINCETON N.J. Feb. 10 2012 PRNewswire Soligenix Inc. OTCBB SNGXD Soligenix or the Company a development stage biopharmaceutical company announced preliminary results today from a Phase 12 clinical trial evaluating SGX201 a timerelease formulation of oral...
↧